These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33215643)

  • 1. The growing spectrum of cardiomyopathies: risk assessment and management.
    Lüscher TF
    Eur Heart J; 2019 Mar; 40(12):945-948. PubMed ID: 33215643
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of pregnancy in cardiomyopathies and heart failure.
    Golia E; Gravino R; Rea A; Masarone D; Rubino M; Cirillo A; Pacileo R; Fratta F; Russo MG; Pacileo G; Limongelli G
    Future Cardiol; 2017 Jan; 13(1):81-96. PubMed ID: 27990841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies.
    González-Torrecilla E; Arenal A; Atienza F; Datino T; Bravo L; Ruiz P; Ávila P; Fernández-Avilés F
    Rev Recent Clin Trials; 2015; 10(2):111-27. PubMed ID: 25845953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series.
    Pereira NL; Grogan M; Dec GW
    J Am Coll Cardiol; 2018 Mar; 71(10):1149-1166. PubMed ID: 29519356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series.
    Pereira NL; Grogan M; Dec GW
    J Am Coll Cardiol; 2018 Mar; 71(10):1130-1148. PubMed ID: 29519355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current applications of biomarkers in cardiomyopathies.
    Coats CJ; Heywood WE; Mills K; Elliott PM
    Expert Rev Cardiovasc Ther; 2015; 13(7):825-37. PubMed ID: 26106935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies.
    Forleo C; D'Erchia AM; Sorrentino S; Manzari C; Chiara M; Iacoviello M; Guaricci AI; De Santis D; Musci RL; La Spada A; Marangelli V; Pesole G; Favale S
    PLoS One; 2017; 12(7):e0181842. PubMed ID: 28750076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiomyopathies. I: classification of cardiomyopathies--dilated cardiomyopathy].
    Schultheiss HP; Noutsias M; Kühl U; Lassner D; Gross U; Poller W; Pauschinger M
    Internist (Berl); 2005 Nov; 46(11):1245-56; quiz 1257. PubMed ID: 16228156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular classification of cardiomyopathies.
    Cecchi F; Tomberli B; Olivotto I
    Glob Cardiol Sci Pract; 2012; 2012(1):4. PubMed ID: 25610835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging-Specific Cardiomyopathies: A Practical Guide.
    Rankin K; Thampinathan B; Thavendiranathan P
    Heart Fail Clin; 2019 Apr; 15(2):275-295. PubMed ID: 30832818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical practice guidelines of the Sociedad Española de Cardiología on cardiomyopathies and myocarditis].
    Galve Basilio E; Alfonso Manterola F; Ballester Rodés M; Castro Beiras A; Fernández de Soria Pantoja R; Penas Lado M; Sánchez Domínguez J
    Rev Esp Cardiol; 2000 Mar; 53(3):360-93. PubMed ID: 10712969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perioperative management of patients with cardiomyopathies: preface and comments].
    Inada E
    Masui; 2014 Jan; 63(1):2-4. PubMed ID: 24558925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment and management of anthracycline and HER2 receptor inhibitor-induced cardiomyopathy.
    Jahangir E; Shah S; Shum K; Baxter C; Fitzpatrick JD; Cole J; Gilliland Y; Polin NM
    South Med J; 2015 Feb; 108(2):71-8. PubMed ID: 25688890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern Imaging Techniques in Cardiomyopathies.
    Jan MF; Tajik AJ
    Circ Res; 2017 Sep; 121(7):874-891. PubMed ID: 28912188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of Inflammation in Unexplained Cardiomyopathy.
    Kadkhodayan A; Chareonthaitawee P; Raman SV; Cooper LT
    JACC Cardiovasc Imaging; 2016 May; 9(5):603-17. PubMed ID: 27151523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gender effect on cardiomyopathy].
    Biagini E; Berardini A; Graziosi M; Rosmini S; Pazzi C; Rapezzi C
    G Ital Cardiol (Rome); 2012 Jun; 13(6):424-31. PubMed ID: 22622122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of cardiomyopathies in 2007.
    Sinagra G; Di Lenarda A; Moretti M; Mestroni L; Pinamonti B; Perkan A; Salvi A; Pyxaras S; Bussani R; Silvestri F; Camerini F
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):545-54. PubMed ID: 18475121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial cardiomyopathy and related arrhythmias.
    Montaigne D; Pentiah AD
    Card Electrophysiol Clin; 2015 Jun; 7(2):293-301. PubMed ID: 26002393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease.
    Quarta G; Papadakis M; Donna PD; Maurizi N; Iacovoni A; Gavazzi A; Senni M; Olivotto I
    Nat Rev Cardiol; 2017 Feb; 14(2):102-112. PubMed ID: 27830773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MOGE(S) classification for cardiomyopathies: current status and future outlook.
    Westphal JG; Rigopoulos AG; Bakogiannis C; Ludwig SE; Mavrogeni S; Bigalke B; Doenst T; Pauschinger M; Tschöpe C; Schulze PC; Noutsias M
    Heart Fail Rev; 2017 Nov; 22(6):743-752. PubMed ID: 28721466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.